Understanding how medicines are made available to New Zealanders
In New Zealand, medicines are registered for use and funded through two separate and distinct processes.
Registration of Medicines in New Zealand
Companies who wish to market their medicine in New Zealand must make an application to Medsafe, the government body responsible for registering medicines. Medsafe reviews the application made by the company and determines whether the medicine meets acceptable standards of safety, quality and efficacy. Medsafe lists all medicines that have been registered for use in New Zealand on its website: www.medsafe.govt.nz
Funding of Medicines in New Zealand
The funding of medicines in New Zealand is overseen by PHARMAC, the government’s purchasing agency for medicines. PHARMAC have a set budget to purchase medicines and unfortunately it is not possible to fund every medicine registered in New Zealand. PHARMAC use a number of criteria to make decisions on which medicines should be funded such as need, health benefit, cost and savings and suitability. For more information on the role of PHARMAC, visit: http://www.pharmac.govt.nz/about/your-guide-to-pha...
Costs of Unfunded Medicines
If you and your doctor decide on an unfunded medicine as a treatment option, you will need to pay for the medicine yourself. In addition, you may need to see a doctor at a private treatment centre. Your specialist will be able to provide you with information on the cost of the medicine and any additional treatment costs. If you have medical insurance, it is worth contacting your provider to ask whether unfunded medicines are covered by your policy.
Roche Patient Access Programmes
Roche have introduced a number of patient access programmes which provide unfunded Roche cancer medicines at a reduced cost. If you would like to find out more about Roche’s medicines and our access programmes, visit www.cancerinfo.co.nz
Roche Products (New Zealand) Ltd. PO Box 109113, Newmarket, Auckland 1149 Ph: 0800 656 464 www.roche.co.nz ID2372/TAPS NA 8638.